Jazz Pharmaceuticals
JAZZ
#2036
Rank
S$10.32 B
Marketcap
$169.97
Share price
1.16%
Change (1 day)
7.00%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.91

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.90. In 2022 the company made an earnings per share (EPS) of -$4.76 an increase over its 2021 EPS that were of -$7.23.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.91-59.93%
2022-$4.76-34.2%
2021-$7.23-224.83%
2020$5.79-53.25%
2019$12.3923.59%
2018$10.03-8.24%
2017$10.9323.74%
2016$8.8322.12%
2015$7.23478.49%
2014$1.25-74.93%
2013$4.99-27.11%
2012$6.8469.1%
2011$4.05245.98%
2010$1.17-462.5%
2009-$0.32-96.7%
2008-$9.79-27.04%
2007-$13.4165.47%
2006-$8.11-4.59%
2005-$8.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.40 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.14-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.03-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.69 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel